Electronic estimations of renal function are inaccurate in solid-organ transplant recipients and can result in significant underdosing of prophylactic valganciclovir

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 8, 2013, Pages 4058-4060

  Trevillyan, Janine ^a   Angus, P ^a,c   Shelton, E ^a   Whitlam, J ^a   Ierino, F ^a,c   Pavlovic, J ^a   Gregory, D ^a   Urbancic, K ^a   Torresi, J ^a,c   Testro, A ^a,c   Grayson, M L ^a,b,c  

^a AUSTIN HEALTH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; VALGANCICLOVIR;

ADULT; ARTICLE; CLINICAL ARTICLE; CREATININE CLEARANCE; CREATININE URINE LEVEL; CYTOMEGALOVIRUS INFECTION; DRUG BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HIGH RISK PATIENT; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; PATIENT ASSESSMENT; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RECOMMENDED DRUG DOSE; TREATMENT DURATION;

ADULT; ANTIVIRAL AGENTS; AUTOMATIC DATA PROCESSING; CREATINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 84880303562     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00375-13     Document Type: Article

References (15)

1. Hodson EM, Ladhani M, Webster AC, Strippoli GF, Craig JC. 2013. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst. Rev. 2:CD003774. doi: 10.1002/14651858. CD003774.pub4.
2. Limaye AP. 2002. Ganciclovir-resistant cytomegalovirus in organ transplant recipients. Clin. Infect. Dis. 35:866-872.
3. Genentech. 2009. Valcyte. Product information. Genentech, Inc., South San Francisco, C. A.
4. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. 1999. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 130:461-470.
5. Cockcroft DW, Gault MH. 1976. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41.
6. Boulieu R, Gallant C, Silberstein N. 1997. Determination of acyclovir in human plasma by high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 693:233-236.
7. Fishman JA, Doran MT, Volpicelli SA, Cosimi AB, Flood JG, Rubin RH. 2000. Dosing of intravenous ganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplant recipients. Transplantation 69:389-394.
8. Piketty C, Bardin C, Gilquin J, Gairard A, Kazatchkine MD, Chast F. 2000. Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis. Clin. Microbiol. Infect. 6:117-120.
9. Sanchez JL, Storch GA. 2002. Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA. J. Clin. Microbiol. 40:2381-2386.
10. Razonable RR. 2010. Cytomegalovirus infection in transplantation. In Scheld WM, Grayson ML, Hughes JM (ed), Emerging infections. ASM Press, Washington, D. C.
11. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. 2009. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150: 604-612.
12. Tidman M, Sjostrom P, Jones I. 2008. A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two. Nephrol. Dial. Transplant. 23:154-160.
13. Erice A, Jordan MC, Chace BA, Fletcher C, Chinnock BJ, Balfour HH, Jr. 1987. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts. JAMA 257:3082-3087.
14. Kalil AC, Mindru C, Florescu DF. 2011. Effectiveness of valganciclovir 900 mg versus 450 mg for cytomegalovirus prophylaxis in transplantation: direct and indirect treatment comparison meta-analysis. Clin. Infect. Dis. 52:313-321.
15. Chamberlain CE, Penzak SR, Alfaro RM, Wesley R, Daniels CE, Hale D, Kirk AD, Mannon RB. 2008. Pharmacokinetics of low and maintenance dose valganciclovir in kidney transplant recipients. Am. J. Transplant. 8:1297-1302.